From: Risk factors for early progression of diffuse low-grade glioma in adults
Variable | PFS ≤ 60 months (n = 14) | PFS > 60 months (n = 30) | χ2/Z | p-Value |
---|---|---|---|---|
Sex, n (%) | 3.727 | 0.054 | ||
Male | 9 (64.3) | 10 (33.3) | ||
Female | 5 (35.7) | 20 (66.7) | ||
Age, years, n (%) | 0.786 | 0.375 | ||
≥ 40 | 9 (64.3) | 15 (50.0) | ||
< 40 | 5 (35.7) | 15 (50.0) | ||
Tumor location, n (%) | 2.235 | 0.135 | ||
Superfical | 8 (57.1) | 25 (83.3) | ||
Deep | 6 (42.9) | 5 (16.7) | ||
Preoperative tumor volume, cm3, n (%) | 3.020 | 0.082 | ||
≤ 30 | 4 (28.6) | 17 (56.7) | ||
> 30 | 10 (71.4) | 13 (43.3) | ||
Tumor range, n (%) | 2.937 | 0.087 | ||
Single lobe | 5 (35.7) | 19 (63.3) | ||
Multiple lobe | 9 (64.3) | 11 (36.7) | ||
EOR, n (%) | −4.239a | 0.000 | ||
100 | 0 (0) | 22 (73.3) | ||
90–99 | 11 (78.6) | 6 (20.0) | ||
< 90 | 3 (21.4) | 2 (6.7) | ||
Treatment after first surgery, n (%) | 0.172 | 0.982 | ||
RT alone | 3 (21.4) | 7 (23.3) | ||
Chemotherapy alone | 2 (14.3) | 4 (13.4) | ||
RT + chemotherapy | 5 (35.7) | 12 (40.0) | ||
None | 4 (28.6) | 7 (23.3) |